513 related articles for article (PubMed ID: 25998895)
1. T-peak to T-end interval for prediction of ventricular tachyarrhythmia and mortality in a primary prevention population with systolic cardiomyopathy.
Rosenthal TM; Stahls PF; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Xue JQ; Morin DP
Heart Rhythm; 2015 Aug; 12(8):1789-97. PubMed ID: 25998895
[TBL] [Abstract][Full Text] [Related]
2. Relationships between the T-peak to T-end interval, ventricular tachyarrhythmia, and death in left ventricular systolic dysfunction.
Morin DP; Saad MN; Shams OF; Owen JS; Xue JQ; Abi-Samra FM; Khatib S; Nelson-Twakor OS; Milani RV
Europace; 2012 Aug; 14(8):1172-9. PubMed ID: 22277646
[TBL] [Abstract][Full Text] [Related]
3. Optimal method of measuring the T-peak to T-end interval for risk stratification in primary prevention.
Rosenthal TM; Masvidal D; Abi Samra FM; Bernard ML; Khatib S; Polin GM; Rogers PA; Xue JQ; Morin DP
Europace; 2018 Apr; 20(4):698-705. PubMed ID: 28339886
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.
Streitner F; Kuschyk J; Dietrich C; Mahl E; Streitner I; Doesch C; Veltmann C; Schimpf R; Wolpert C; Borggrefe M
Clin Cardiol; 2011 Oct; 34(10):604-9. PubMed ID: 21887690
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy.
Bender SR; Friedman DJ; Markowitz SM; Lerman BB; Okin PM
J Interv Card Electrophysiol; 2012 Sep; 34(3):237-45. PubMed ID: 22354775
[TBL] [Abstract][Full Text] [Related]
6. Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.
Grimm W; Hoffmann J Jü; Müller HH; Maisch B
J Am Coll Cardiol; 2002 Mar; 39(5):780-7. PubMed ID: 11869841
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
[TBL] [Abstract][Full Text] [Related]
8. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
Alsheikh-Ali AA; Link MS; Semsarian C; Shen WK; Estes NA; Maron MS; Haas TS; Formisano F; Boriani G; Spirito P; Maron BJ
Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573
[TBL] [Abstract][Full Text] [Related]
9. J Waves Are Associated With the Increased Occurrence of Life-Threatening Ventricular Tachyarrhythmia in Patients With Nonischemic Cardiomyopathy.
Naruse Y; Nogami A; Shinoda Y; Hanaki Y; Shirai Y; Kowase S; Kurosaki K; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
J Cardiovasc Electrophysiol; 2016 Dec; 27(12):1448-1453. PubMed ID: 27593399
[TBL] [Abstract][Full Text] [Related]
10. Interlead heterogeneity of R- and T-wave morphology in standard 12-lead ECGs predicts sustained ventricular tachycardia/fibrillation and arrhythmic death in patients with cardiomyopathy.
Tan AY; Nearing BD; Rosenberg M; Nezafat R; Josephson ME; Verrier RL
J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1324-1333. PubMed ID: 28675579
[TBL] [Abstract][Full Text] [Related]
11. Dyssynchrony and the risk of ventricular arrhythmias.
Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
[TBL] [Abstract][Full Text] [Related]
12. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
13. Intracardiac QT integral on far-field ICD electrogram predicts sustained ventricular tachyarrhythmias in ICD patients.
Tereshchenko LG; Ghanem RN; Abeyratne A; Swerdlow CD
Heart Rhythm; 2011 Dec; 8(12):1889-94. PubMed ID: 21802390
[TBL] [Abstract][Full Text] [Related]
14. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
[TBL] [Abstract][Full Text] [Related]
15. Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.
Zareba W; Daubert JP; Beck CA; Huang DT; Alexis JD; Brown MW; Pyykkonen K; McNitt S; Oakes D; Feng C; Aktas MK; Ayala-Parades F; Baranchuk A; Dubuc M; Haigney M; Mazur A; McPherson CA; Mitchell LB; Natale A; Piccini JP; Raitt M; Rashtian MY; Schuger C; Winters S; Worley SJ; Ziv O; Moss AJ;
J Am Coll Cardiol; 2018 Aug; 72(6):636-645. PubMed ID: 30071993
[TBL] [Abstract][Full Text] [Related]
16. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
[TBL] [Abstract][Full Text] [Related]
17. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
18. Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.
Sesselberg HW; Moss AJ; McNitt S; Zareba W; Daubert JP; Andrews ML; Hall WJ; McClinitic B; Huang DT;
Heart Rhythm; 2007 Nov; 4(11):1395-402. PubMed ID: 17954398
[TBL] [Abstract][Full Text] [Related]
19. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
Haigney MC; Zareba W; Gentlesk PJ; Goldstein RE; Illovsky M; McNitt S; Andrews ML; Moss AJ;
J Am Coll Cardiol; 2004 Oct; 44(7):1481-7. PubMed ID: 15464332
[TBL] [Abstract][Full Text] [Related]
20. Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.
Gillis AM; Sheldon RS; Wyse DG; Duff HJ; Cassidy MR; Mitchell LB
J Cardiovasc Electrophysiol; 2003 May; 14(5):492-8. PubMed ID: 12776866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
